Plain language summary of MARIPOSA-2: amivantamab-chemotherapy either with or without lazertinib for treatment of non-small-cell lung cancer

Antonio Passaro, Alexis B. Cortot, Ryan D. Gentzler, Karen L. Reckamp, Sujay Shah, William Nassib William, Byoung Chul Cho

Open source

DOI: 10.1080/14796694.2025.2492456
Published: 2025-05-06
Container: Future Oncology
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2025.2492456,
  title = {Plain language summary of MARIPOSA-2: amivantamab-chemotherapy either with or without lazertinib for treatment of non-small-cell lung cancer},
  author = {Antonio Passaro and Alexis B. Cortot and Ryan D. Gentzler and Karen L. Reckamp and Sujay Shah and William Nassib William and Byoung Chul Cho},
  year = {2025},
  journal = {Future Oncology},
  doi = {10.1080/14796694.2025.2492456},
  url = {https://doi.org/10.1080/14796694.2025.2492456}
}

RIS

TY  - JOUR
TI  - Plain language summary of MARIPOSA-2: amivantamab-chemotherapy either with or without lazertinib for treatment of non-small-cell lung cancer
AU  - Antonio Passaro
AU  - Alexis B. Cortot
AU  - Ryan D. Gentzler
AU  - Karen L. Reckamp
AU  - Sujay Shah
AU  - William Nassib William
AU  - Byoung Chul Cho
PY  - 2025
JO  - Future Oncology
DO  - 10.1080/14796694.2025.2492456
UR  - https://doi.org/10.1080/14796694.2025.2492456
ER  -

APA

Passaro, A., Cortot, A. B., Gentzler, R. D., Reckamp, K. L., Shah, S., William, W. N., & Cho, B. C. (2025). Plain language summary of MARIPOSA-2: amivantamab-chemotherapy either with or without lazertinib for treatment of non-small-cell lung cancer. Future Oncology. https://doi.org/10.1080/14796694.2025.2492456

Source records

crossref · retrieved 2026-09-27T04:43:50.267Z